OralTopicalDosed ingredientTherapeutic flag Cosmetic cross-reference

Aminolevulinic Acid Hydrochloride

CAS 5451-09-2

Aminolevulinic Acid Hydrochloride (CAS 5451-09-2) is a Phase 4 pharmaceutical compound with 2 bioactivity targets and 17 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
2
SOURCE DrugCentral
Adverse signals
17
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Aminolevulinic Acid Hydrochloride
CAS Number
5451-09-2
UNII
V35KBM8JGR
InChIKey
ZLHFONARZHCSET-UHFFFAOYSA-N
ChEMBL ID
CHEMBL1200582
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
dosed ingredientoraltherapeutic flagtopical
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)
Approved or marketed human pharmaceutical use is represented in the source phase field.
ChEMBL CHEMBL1200582 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE EMBL-EBI ChEMBL 2 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- Potency 15619 nM 2 -
- AC50 707.9 nM 1 -
SOURCE NLM RxNorm 2 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
AMINOLEVULINIC ACID HYDROCHLORIDE 261715 SU MTHSPL
aminolevulinic acid hydrochloride 261715 PIN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Aminolevulinic Acid Hydrochloride used for in pharmaceutical contexts?

Aminolevulinic Acid Hydrochloride (CAS 5451-09-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Aminolevulinic Acid Hydrochloride?

Aminolevulinic Acid Hydrochloride has 17 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Drug ineffective, Dysphagia, Feeding intolerance, General physical health deterioration, Glioblastoma. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Aminolevulinic Acid Hydrochloride also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Aminolevulinic Acid HCl with EU status "prohibited".

What clinical phase is Aminolevulinic Acid Hydrochloride in?

Aminolevulinic Acid Hydrochloride is rendered with ChEMBL max phase 4 (approved).